-
Understanding Drivers on Healthcare Resource Utilization Costs Among People Living With Obesity in UK Clinical Practice
Sep 9, 2025, 16:22 PM -
Missed Opportunities in the Diagnosis and Management of Stage 3 Chronic Kidney Disease in General Practice: Insights From the Italian THIN Database
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Health Economics: Opportunities and Challenges for the Future: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Reforming the Delivery of Smoking Cessation: A Distributional Cost-Effectiveness Analysis of Providing Smoking Cessation as Part of Targeted Lung Cancer Screening in England
Sep 9, 2025, 16:22 PM -
Costs and Number Needed to Treat (NNT) to Achieve Improvements With C5 Inhibitors in Generalized Myasthenia Gravis From the Japanese Healthcare Perspective: A Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparisons (MAICs) and Network Meta-Analyses (NMAs) of the Oral Small-Molecule Chaperone Migalastat vs. Intravenous Enzyme Replacement Therapies (ERTs) for Clinical Measures in Fabry Disease
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM -
Decoding the Future: How Are HTA Agencies Evaluating AI in Healthcare?
Sep 9, 2025, 16:22 PM -
Optimizing Workforce Efficiency and Reducing Waiting Lists Through Remote Monitoring in Obstructive Sleep Apnea (OSA) Care in NHS
Sep 9, 2025, 16:22 PM -
The Use of Real-World Evidence in Health Technology Assessment and the Application of the NICE RWE Framework: A Review of NICE Technology Appraisals
Sep 9, 2025, 16:22 PM -
Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Use of Data From Phase 3 RCTs in Earlier Lines of Therapy in Support of Noncomparative Evidence From Pivotal Phase 2 Studies
Sep 9, 2025, 16:22 PM -
Exploring Nordic Real-World Evidence Sources for a PICO Assessment of a Hypothetical Oncology Drug and Medical Device Product
Sep 9, 2025, 16:22 PM -
Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Sep 9, 2025, 16:22 PM -
Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma
Sep 9, 2025, 16:22 PM -
Developing Best Practice for Generative AI in Health Economic Evaluation: Evidence From a Systematic Review and Stakeholder Engagement
Sep 9, 2025, 16:22 PM -
Procalcitonin-Guided Antimicrobial Stewardship for Sepsis and Lower Respiratory Tract Infections: A Budget Impact Analysis for the Perspective of the Patients in India
Sep 9, 2025, 16:22 PM
